Asia-Pacific Liquid Biopsy Market By Cancer Type 2018-2023
Asia-Pacific Liquid Biopsy market is expected to increase at a CAGR of 31.23% in the forecast period of 2018-2023 and reach a value of USD 681.12 million by 2023 from USD 175.01 million in 2018.
(EMAILWIRE.COM, October 09, 2018 ) Overview:
While tissue biopsies are standard for cancer diagnosis for past many years, their extremely invasive nature and often associated complications are major concerns. Moreover, these biopsies result in high expenditure being incurred by patients. Liquid biopsies, on the other hand, offer a less invasive methodology along with high effectiveness. Thus, there are a number of key personal organizations concerned in rigorous R&D activities for liquid biopsy, diagnostic assay, test development and it’s only a matter of time before these procedures grow in prominence in diagnostic equipment of oncologists and pathologists.
View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/request-sample
Asia Pacific Liquid Biopsy Market size was around USD 175.01 million in 2018. It is expected to grow at a CAGR of 31.23% to reach USD 681.12 million by 2023.
Drivers and Restraints:
Factors driving the Liquid Biopsy market are Increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives taken by government and global health organizations; these are replacing tissue diagnosis procedures. High expenditure is the restraint which effects growth of the market.
To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/
Geographic Segmentation
The Asia Pacific Liquid Biopsy market has geographically segmented into China, India, Japan, South Korea, and Australia. India and China are the Emerging countries in the Asia-Pacific region and expected to grow fast because of increased market access of each country’s population to healthcare resources.
Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/customize-report
Major companies in the market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natter, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
While tissue biopsies are standard for cancer diagnosis for past many years, their extremely invasive nature and often associated complications are major concerns. Moreover, these biopsies result in high expenditure being incurred by patients. Liquid biopsies, on the other hand, offer a less invasive methodology along with high effectiveness. Thus, there are a number of key personal organizations concerned in rigorous R&D activities for liquid biopsy, diagnostic assay, test development and it’s only a matter of time before these procedures grow in prominence in diagnostic equipment of oncologists and pathologists.
View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/request-sample
Asia Pacific Liquid Biopsy Market size was around USD 175.01 million in 2018. It is expected to grow at a CAGR of 31.23% to reach USD 681.12 million by 2023.
Drivers and Restraints:
Factors driving the Liquid Biopsy market are Increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives taken by government and global health organizations; these are replacing tissue diagnosis procedures. High expenditure is the restraint which effects growth of the market.
To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/
Geographic Segmentation
The Asia Pacific Liquid Biopsy market has geographically segmented into China, India, Japan, South Korea, and Australia. India and China are the Emerging countries in the Asia-Pacific region and expected to grow fast because of increased market access of each country’s population to healthcare resources.
Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/customize-report
Major companies in the market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natter, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results